In female survivors of breast cancer, the SIRs reported in our study were broadly consistent with those reported in previous literature.5, 6, 7 The increased risk of ovarian cancer could relate to shared hormonal and genetic (eg, BRCA1 and BRCA2 mutations) risk factors.30 Here, BRCA2 is linked to ovarian cancer.